News
-
-
-
COMMUNIQUÉ DE PRESSE
Tacalyx Appoints Jean Engela as Chief Executive Officer to Spearhead Next Phase of Growth
Tacalyx appoints Jean Engela as Chief Executive Officer to spearhead next phase of growth. Bringing over two decades of experience in drug research and development. Company to focus on developing novel TACA cancer therapies -
-
-
COMMUNIQUÉ DE PRESSE
Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs
Tacalyx extends seed round to over €14 M led by Thuja Capital to advance development of cancer therapeutics targeting TACAs, aiming to create novel treatment options for patients with specificity across solid tumor indications
